PRECISION BIOSCIENCES INC Income (Loss) from Continuing Operations, Per Diluted Share
PRECISION BIOSCIENCES INC (DTIL) reported Income (Loss) from Continuing Operations, Per Diluted Share of -$3.63 per share for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare · last filed 2026-03-12
- PRECISION BIOSCIENCES INC income (loss) from continuing operations, per diluted share for the quarter ending 2025-09-30 was -$1.84.
- PRECISION BIOSCIENCES INC income (loss) from continuing operations, per diluted share for the quarter ending 2025-06-30 was -$2.13, a 145.61% decline year-over-year.
- PRECISION BIOSCIENCES INC income (loss) from continuing operations, per diluted share for the quarter ending 2025-03-31 was -$2.21, a 230.00% decline year-over-year.
- PRECISION BIOSCIENCES INC income (loss) from continuing operations, per diluted share for the quarter ending 2024-09-30 was -$2.25.
- PRECISION BIOSCIENCES INC income (loss) from continuing operations, per diluted share for fiscal 2025 was -$3.63, a 449.04% decline from fiscal 2024.
- PRECISION BIOSCIENCES INC income (loss) from continuing operations, per diluted share for fiscal 2024 was $1.04.
- PRECISION BIOSCIENCES INC income (loss) from continuing operations, per diluted share for fiscal 2023 was -$11.07.
- PRECISION BIOSCIENCES INC income (loss) from continuing operations, per diluted share for fiscal 2022 was -$24.88.
| Period end | Income (Loss) from Continuing Operations, Per Diluted Share 3 month | Income (Loss) from Continuing Operations, Per Diluted Share 3 month as first filed | Income (Loss) from Continuing Operations, Per Diluted Share 6 month | Income (Loss) from Continuing Operations, Per Diluted Share 9 month | Income (Loss) from Continuing Operations, Per Diluted Share 9 month as first filed | Income (Loss) from Continuing Operations, Per Diluted Share 12 month |
|---|---|---|---|---|---|---|
| 2025-12-31 | -$3.63 10-K · filed 2026-03-12 | |||||
| 2025-09-30 | -$1.84 10-Q · filed 2025-11-03 | -$6.14 10-Q · filed 2025-11-03 | ||||
| 2025-06-30 | -$2.13 10-Q · filed 2025-08-07 | -$4.33 10-Q · filed 2025-08-07 | ||||
| 2025-03-31 | -$2.21 10-Q · filed 2025-05-15 | |||||
| 2024-12-31 | $1.04 10-K · filed 2026-03-12 | |||||
| 2024-09-30 | -$2.25 10-Q · filed 2025-11-03 | $3.78 10-Q · filed 2025-11-03 | ||||
| 2024-06-30 | $4.67 10-Q · filed 2025-08-07 | $6.81 10-Q · filed 2025-08-07 | ||||
| 2024-03-31 | $1.70 10-Q · filed 2025-05-15 | |||||
| 2023-12-31 | -$11.07 10-K · filed 2025-03-26 | |||||
| 2023-09-30 | -$3.15 10-Q · filed 2024-11-04 | -$0.11 10-Q · filed 2023-11-07 | -$7.69 10-Q · filed 2024-11-04 | -$0.26 10-Q · filed 2023-11-07 | ||
| 2023-06-30 | -$0.80 10-Q · filed 2024-08-01 | -$4.52 10-Q · filed 2024-08-01 | ||||
| 2023-03-31 | -$3.76 10-Q · filed 2024-05-13 | |||||
| 2022-12-31 | -$24.88 10-K · filed 2024-03-27 | |||||
| 2022-09-30 | -$0.14 10-Q · filed 2023-11-07 | -$0.67 10-Q · filed 2023-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |